Montelukast protects against rotenone-induced neurotoxicity in human neuroblastoma cells through regulation of the p38MAPK signaling pathway
Cysteinyl leukotriene receptor 1 (CysLTR1) has been implicated in various inflammatory conditions; however, its role in Parkinson’s disease (PD) pathogenesis remains to be explored. This study elucidated the neuroprotective potential of montelukast pre-treatment in rotenone-exposed SH-SY5Y cells in vitro. Notably, mont...